Rexoby Pharmaceutical Private Limited

Rexoby Pharmaceutical Private Limited - pharma in Noida, Uttar Pradesh, India. Directors, charges & compliance details.
CIN U24100UP2020PTC134664 Incorporated 15 September 2020 ROC Uttar Pradesh HQ Noida, Uttar Pradesh, India
Active Private Limited Company pharma Startup India MSME · Micro
Revenue · FY 2024
₹3.89 Lakh
▼ 68% YoY
Net loss · FY 2024
₹3.05 Lakh
Net margin -78.4%
EBITDA · FY 2024
-₹3.04 Lakh
EBITDA margin -78.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered

About Rexoby Pharmaceutical Private Limited

Data last updated:

Rexoby Pharmaceutical Private Limited is a private limited company based in Noida, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 September 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24100UP2020PTC134664. Its GSTIN is 09AAKCR4465R2ZC (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gita and Sachin Yadav.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bh – 199 Sector – 70 Noida Gautam Buddha Nagar, Uttar Pradesh, India – 201301.

As per the financials filed for FY 2024, the company reported a revenue of ₹3.89 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹3.05 Lakh (net margin -78.4%) and EBITDA of -₹3.04 Lakh (EBITDA margin -78.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.

Rexoby Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-02-0014904).

Company details

CIN U24100UP2020PTC134664
Registration Number 134664
Incorporation Date 15 September 2020
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-UP-02-0014904

Recognitions & Rankings of Rexoby Pharmaceutical

Startup India Government of India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-UP-02-0014904

Contact details

Rexoby Pharmaceutical Private Limited's registered office is in Noida, Uttar Pradesh.

  • Registered Address
    Bh – 199 Sector – 70 Noida Gautam Buddha Nagar, Uttar Pradesh, India – 201301
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Rexoby Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Rexoby Pharmaceutical is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Rexoby Pharmaceutical Private Limited, buy the company report.

Financials of Rexoby Pharmaceutical Private Limited

FY 2025 filings available

Rexoby Pharmaceutical Private Limited reported revenue of ₹3.89 Lakh (down 68% YoY) for FY 2024.

Revenue · FY 2024
₹3.89 Lakh ▼ 68%
Net loss · FY 2024
₹3.05 Lakh margin -78.4%
EBITDA · FY 2024
-₹3.04 Lakh margin -78.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 68%
3 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 470%
3 years · compounded
▼ 32%

Revenue fell 68% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA fell 470% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹3.04 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹3.05 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-78.2%
Net Profit Margin-78.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rexoby Pharmaceutical Private Limited, buy the company report.

Board of directors of Rexoby Pharmaceutical Private Limited

Rexoby Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
GitaDirector05 Jul 20233 Years 4 MonthsCurrent
Sachin YadavDirector15 Sep 20206 Years 2 MonthsCurrent

Peer comparison

Rexoby Pharmaceutical Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Cma Genesis Remedies Private Limited₹3.98 Lakh (FY 2016)-1.0%Mumbai, Maharashtra, India
Savicure Remedies Private Limited₹3.94 Lakh (FY 2020)New Delhi, Delhi, India
Rexoby Pharmaceutical Private Limitedthis company₹3.89 Lakh (FY 2024)-₹3.05 Lakh-78.4%-68.0%Noida, Uttar Pradesh, India
Pdanil Healthcare Private Limited₹3.88 Lakh (FY 2024)-39.0%Agra, Uttar Pradesh, India
Phyto Medicines Ltd.₹3.84 Lakh (FY 2025)151.0%Kolkata, West Bengal, India

To see the full peer comparison of Rexoby Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rexoby Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Rexoby Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
09AAKCR4465R2ZCUttar PradeshActive13 May 2022

To see the full GST registrations and return filing status of Rexoby Pharmaceutical Private Limited, buy the company report.

Recent activity

Rexoby Pharmaceutical Private Limited has 6 board changes on record since 2020: 4 appointments and 2 cessations. The latest: Gita was appointed as Director on 05 Jul 2023.

AGM
Rexoby Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rexoby Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Appointed
Gita was appointed as Director.
Appointed
Shree Nivas was appointed as Director.
Ceased
Kumari Simpal ceased to be Director.
Ceased
Shree Nivas ceased to be Director.
Appointed
Banwari Lal Yadav was appointed as Director.
Appointed
Sachin Yadav was appointed as Director.
Incorporation
15 Sep 2020
Rexoby Pharmaceutical Private Limited was registered on 15 Sep 2020 with Roc Uttar Pradesh Ii & aged 6 years 2 months as per MCA records.

Frequently asked questions

Rexoby Pharmaceutical is an active private limited company based in Noida, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 September 2020 (6+ years old) and is registered under CIN U24100UP2020PTC134664.

Rexoby Pharmaceutical has 2 current directors:

The latest financial statements of Rexoby Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Rexoby Pharmaceutical is 09AAKCR4465R2ZC, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Rexoby Pharmaceutical is U24100UP2020PTC134664. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rexoby Pharmaceutical was incorporated on 15 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

The peers of Rexoby Pharmaceutical by revenue are Cma Genesis Remedies Private Limited, Savicure Remedies Private Limited, Pdanil Healthcare Private Limited, Phyto Medicines Ltd, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Gita was appointed as Director on 05 Jul 2023. Shree Nivas was appointed as Director on 05 Oct 2022. Kumari Simpal ceased to be Director on 18 May 2022. Rexoby Pharmaceutical has 6 board changes on record in total.

Yes, Rexoby Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Rexoby Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-02-0014904).

The registered office of Rexoby Pharmaceutical is at Bh – 199 Sector – 70 Noida Gautam Buddha Nagar, Uttar Pradesh, India – 201301.